(Reuters) - U.S. infectious disease expert Anthony Fauci said on Thursday that efforts are underway in the U.S. to push for the development of antivirals and other therapies for early intervention during the course of the COVID-19 respiratory illness.
Fauci's comments come days after the United States authorized emergency use of Eli Lilly & Co's bamlanivimab, the first experimental antibody drug for COVID-19 in patients who are not hospitalized, but are at risk of serious illness because of their age or other conditions.